US2018194821A1PendingUtilityA1

Regulators of nfat

Assignee: CHILDRENS MEDICAL CENTERPriority: Jan 5, 2006Filed: Feb 20, 2018Published: Jul 12, 2018
Est. expiryJan 5, 2026(expired)· nominal 20-yr term from priority
C07K 16/18C12N 15/907C12N 15/63C07H 21/04C07K 14/4702A61K 35/12C12N 2510/00G01N 33/5041C12N 5/16C12Q 1/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are methods of identifying an agent that modulates an NFAT regulator protein. One such method comprises contacting at least one test agent with a recombinant cell comprising at least one NFAT regulator protein or fragment or derivative thereof, assessing the effect of the test agent on an activity, interaction, expression, or binding to the NFAT regulator protein or fragment or derivative thereof, and identifying the test agent that has an effect on an activity, interaction, expression, or binding to the NFAT regulator protein or fragment or derivative thereof, whereby the identified test agent is characterized as an agent that modulates an NFAT regulator protein. Methods and tools for identifying an agent that modulates intracellular calcium, to screen for an agent that modulates NFAT regulator function, to diagnose unexplained immunodeficiency in a subject, and for identifying an agent for treating or preventing a disease or disorder associated with a NFAT regulator protein or calcium signaling are also disclosed.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A recombinant cell comprising heterologous nucleic acid encoding at least one mammalian Nuclear Factor of Activated T cells (NFAT) regulator protein, wherein the heterologous nucleic acid is a mammalian NFAT regulator gene, wherein the NFAT regulator gene is ORAI selected from ORAI1, ORAI2, ORAI3 or a homologue or derivative thereof; and the recombinant cells is an isolated cell.

Join the waitlist — get patent alerts

Track US2018194821A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.